BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16452814)

  • 1. [Organ preservation, multimodal radical tumor therapy and reduction of therapy-related morbidity--development of diagnostics and therapy of endometrial carcinoma].
    Kimmig R; Fink D; Lang U
    Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):1-2. PubMed ID: 16452814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use and outcomes of minimally invasive hysterectomy for women with nonendometrioid endometrial cancers.
    Nieto VL; Huang Y; Hou JY; Tergas AI; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2018 Nov; 219(5):463.e1-463.e12. PubMed ID: 30086293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary issues in the management of endometrial cancer.
    Barakat RR
    CA Cancer J Clin; 1998; 48(5):299-314. PubMed ID: 9742896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Endometrial Cancer: A Review.
    Suri V; Arora A
    Rev Recent Clin Trials; 2015; 10(4):309-16. PubMed ID: 26411949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
    Feng W; Hua K; Malpica A; Zhou X; Baak JP
    Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of minimally invasive surgery for patients with endometrial carcinoma involving the cervix.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
    Int J Gynecol Cancer; 2020 May; 30(5):619-625. PubMed ID: 32276935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy of uterine clear cell carcinoma: a review.
    Xu Y; Hanna RK; Elshaikh MA
    Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant postoperative treatment of endometrial cancer].
    Vergote IB
    Gynakologe; 1994 Apr; 27(2):84-8. PubMed ID: 8039747
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
    Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
    J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Failures and Clinical Outcome of Patients with Early-Stage, High-Risk, Node-Negative Endometrial Cancer Treated with Surgery Followed by Adjuvant Platinum-Based Chemotherapy and Vaginal Brachytherapy.
    Laliscia C; Cosio S; Morganti R; Mazzotti V; Fabrini MG; Paiar F; Gadducci A
    Oncology; 2019; 96(5):235-241. PubMed ID: 30904907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ preservation and functional rehabilitation in head and neck: introduction.
    Gullane PJ; O'Sullivan B
    World J Surg; 2003 Jul; 27(7):804. PubMed ID: 14509510
    [No Abstract]   [Full Text] [Related]  

  • 13. Endometrial cancer.
    Hanf V; Günthert AR; Emons G
    Onkologie; 2003 Oct; 26(5):429-36. PubMed ID: 14605458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive surgery does not impair overall survival in stage IIIC endometrial cancer patients.
    Papadia A; Garbade A; Gasparri ML; Wang J; Radan AP; Mueller MD
    Arch Gynecol Obstet; 2020 Feb; 301(2):585-590. PubMed ID: 31781888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic survival of women after surgery for endometrial cancer].
    Roszak A
    Ginekol Pol; 1994 Sep; 65(9):486-90. PubMed ID: 7721160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of quality of care on racial disparities in survival for endometrial cancer.
    Huang AB; Huang Y; Hur C; Tergas AI; Khoury-Collado F; Melamed A; St Clair CM; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2020 Sep; 223(3):396.e1-396.e13. PubMed ID: 32109459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes and patterns of failure in women with stage IIIC
    Lee JK; Mahan M; Hanna RK; Elshaikh MA
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer.
    Ayhan A; Taskiran C; Celik C; Yuce K; Kucukali T
    Int J Gynecol Cancer; 2002; 12(5):448-53. PubMed ID: 12366661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?
    Lan C; Huang X; Huang Q; Wang Y; Gu H; Li Y; Liu J
    Int J Gynecol Cancer; 2015 Oct; 25(8):1445-52. PubMed ID: 26397067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.